GO:0046711 GDP biosynthetic process | Genes & Methods

Guanosine 5'-diphosphate (GDP) is a purine nucleotide that occupies a central position in cellular metabolism and signal transduction. The Gene Ontology term GO:0046711, GDP biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of GDP. GDP is not merely a metabolic intermediate; it is the nucleotide-bound state of many regulatory GTPases, including Ras-family proteins, Rab GTPases, ARF GTPases and heterotrimeric G-protein alpha subunits, where the GDP-bound form represents the inactive state that is exchanged for GTP upon activation [2, 4, 5, 6]. Consequently, the pathways that generate GDP are intimately connected to the regulation of cell growth, vesicle trafficking, secretion and receptor-coupled signaling. Understanding GDP biosynthesis is important because the availability of guanosine nucleotides influences a wide range of cellular processes. GDP is produced through the guanosine nucleotide biosynthetic pathway, which branches from inosine monophosphate (IMP) and leads to both GDP and GTP. In engineered microbial systems, modulation of guanosine nucleotide biosynthetic pathways has been shown to enhance GDP-L-fucose production, demonstrating that flux through GDP biosynthesis can be redirected for biotechnological purposes. In addition, GDP is a substrate in the biosynthesis of complex natural products such as the antidiabetic drug acarbose, where the complete biosynthetic pathway has been elucidated. For researchers, GO:0046711 provides a framework for annotating genes and enzymes involved in GDP formation and for interpreting experimental data from metabolomics, flux analysis and genetic perturbation studies. Because GDP is the product of multiple enzymatic steps and the substrate for numerous downstream reactions, its biosynthesis intersects with nucleotide metabolism, glycosylation, protein synthesis and signal transduction [2, 3, 7, 8]. This article reviews the definition, mechanism, key genes, disease relevance and research methods associated with GDP biosynthetic process, with an emphasis on how CRISPR-based models can be used to dissect this pathway.

GO:0046711, GDP biosynthetic process, is the biological process comprising the chemical reactions and pathways that result in the formation of GDP, guanosine 5'-diphosphate. It encompasses the enzymatic steps that convert precursor nucleotides into GDP, including the de novo purine biosynthetic route that branches toward guanosine nucleotides and the phosphorylation/dephosphorylation reactions that generate GDP from GMP or GTP. The term is synonymous with GDP anabolism, GDP biosynthesis, GDP formation and GDP synthesis.

GDP biosynthetic process is important because GDP is both a metabolic product and a signaling molecule. As the GDP-bound state of small GTPases such as Ras, Rab, ARF and heterotrimeric G-protein alpha subunits, GDP controls the activation cycle of these molecular switches, which regulate cell proliferation, membrane trafficking and receptor-coupled signaling [2, 4, 5, 6]. In addition, GDP is a precursor for GDP-sugars such as GDP-L-fucose, which is required for fucosylation of glycoproteins and glycolipids, and modulation of guanosine nucleotide biosynthetic pathways can enhance GDP-L-fucose production in recombinant Escherichia coli. GDP is also a substrate in the biosynthesis of the antidiabetic drug acarbose, highlighting its role in secondary metabolism. Finally, guanosine nucleotide levels are linked to translation initiation through eIF2, which binds GTP and GDP during the initiation cycle. Thus, understanding GDP biosynthesis provides insight into cancer, metabolic disorders, protein synthesis control and biotechnological production of valuable compounds.

The following genes and proteins are involved in GDP biosynthetic process, either as biosynthetic enzymes, interconverting kinases or GDP-binding regulatory proteins.

GDP biosynthetic process is regulated at multiple levels. The guanosine nucleotide biosynthetic pathway is controlled by feedback inhibition of IMP dehydrogenase and GMP synthase by guanine nucleotides, and by the availability of precursors such as IMP. In signaling, the GDP-bound state of GTPases is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), which control the timing of GDP release and GTP hydrolysis [2, 4, 5, 6]. Translation initiation factor eIF2 cycles between GDP- and GTP-bound states, and its regulation by guanine nucleotide exchange factor eIF2B couples GDP availability to protein synthesis. In metabolic engineering, modulation of guanosine nucleotide biosynthetic pathways can redirect flux toward GDP-L-fucose production, indicating that pathway regulation is responsive to genetic and environmental changes.

Mutations in KRAS that alter GDP binding, such as G12C, G12D, G12R and G12V, are among the most common oncogenic drivers. Molecular dynamics studies have explored GDP binding to wild-type and mutant KRas and its interaction with the inhibitor MRTX1133, highlighting the importance of the GDP-bound state in drug design. Because GDP biosynthesis supplies the nucleotide that occupies the inactive state of Ras, enzymes in this pathway are of interest for understanding oncogenic signaling.

Rab27a effectors in pancreatic beta-cells are GTP- and GDP-dependent, linking guanosine nucleotide metabolism to insulin granule exocytosis. Dysregulation of GDP/GTP cycling could therefore influence glucose homeostasis and diabetes. In addition, the antidiabetic drug acarbose is produced through a biosynthetic pathway that uses GDP as a substrate, connecting GDP metabolism to therapeutic compound production.

eIF2 binds GDP and GTP during translation initiation, and its regulation is critical for protein synthesis control. Perturbations in guanosine nucleotide metabolism could affect eIF2 function and contribute to stress-related and neurological phenotypes, although direct evidence for GDP biosynthetic enzymes in these conditions remains an active area of research.

Liquid chromatography-mass spectrometry (LC-MS) can quantify GDP and related nucleotides in cell extracts. This method is used to measure changes in GDP pools after genetic perturbation of biosynthetic enzymes or after modulation of guanosine nucleotide pathways.

Steered molecular dynamics simulations have been used to explore GDP binding to wild-type and mutant KRas and to assess interactions with inhibitors such as MRTX1133. These computational approaches complement biochemical binding assays.

CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes involved in GDP biosynthesis. For example, point mutations in KRAS can be introduced to study altered GDP binding, and overexpression of biosynthetic genes can enhance GDP-L-fucose production.

Enzymatic assays for IMP dehydrogenase, GMP synthase, guanylate kinase and nucleoside diphosphate kinase measure the catalytic steps that produce GDP. These assays are used to validate gene function and to screen for inhibitors [2, 7].

Researchers studying GDP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in GDP production, GTPase regulation or downstream disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in the GDP biosynthetic pathway.

GO:0046711 GDP biosynthetic process is a fundamental biological process that supplies GDP, a nucleotide critical for GTPase signaling, translation initiation, glycosylation and secondary metabolism. The pathway intersects with cancer, diabetes and metabolic engineering, as evidenced by studies on KRas GDP binding, Rab27a effectors, eIF2 and GDP-L-fucose production [1, 3, 5, 7, 8]. Understanding the enzymes and regulatory mechanisms of GDP biosynthesis provides a basis for therapeutic and biotechnological applications. CRISPR-based models, including knockout, point mutation, knock-in and overexpression, are powerful tools for dissecting the causal roles of GDP biosynthetic genes. EDITGENE offers comprehensive services to generate these models and to support bioinformatics analysis, enabling researchers to advance the field of guanosine nucleotide metabolism.